Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the ...

“For me, myopia management would be the one thing I would love to see fully-funded in practice. Not only would we be helping ...